The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Neuromyelitis Spectrum Disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649
Self-citationA serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Self-citationIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Self-citationThe clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Self-citationA role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Weinshenker, B. G., O'Brien, P. C., Petterson, T. M., Noseworthy, J. H., Lucchinetti, C. F., Dodick, D. W., Pineda, A. A., Stevens, L. N., & Rodriguez, M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<878::aid-ana10>3.0.co;2-q · Cited by 894
Self-citationDistinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850
Brain Abnormalities in Neuromyelitis Optica
Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.390 · Cited by 675
Self-citationMRI characteristics of neuromyelitis optica spectrum disorder: An international update
Kim, H. J., Paul, F., Lana-Peixoto, M. A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E. C., Sato, D. K., de Seze, J., Wuerfel, J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001367 · Cited by 664
Self-citationAn open label study of the effects of rituximab in neuromyelitis optica
Cree, B. A. C., Lamb, S., Morgan, K., Chen, A., Waubant, E., & Genain, C. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
Pittock, S. J., Lennon, V. A., de Seze, J., Vermersch, P., Homburger, H. A., Wingerchuk, D. M., Lucchinetti, C. F., Zéphir, H., Moder, K., & Weinshenker, B. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.17 · Cited by 608
Self-citationAquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Chihara, N., Aranami, T., Sato, W., Miyazaki, Y., Miyake, S., Okamoto, T., Ogawa, M., Toda, T., & Yamamura, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017385108 · Cited by 474
Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients
(2008) · Archives of Neurology · doi:10.1001/archneur.65.11.noc80069 · Cited by 459
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K., Wegner, B., Hellwig, K., Pache, F., Ruprecht, K., Havla, J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24554 · Cited by 432
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0717-1 · Cited by 429
Multiple sclerosis in the Japanese population
Kira, J.-I. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00308-9 · Cited by 419
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
Lucchinetti, C. F., Guo, Y., Popescu, B. F. G., Fujihara, K., Itoyama, Y., & Misu, T. (2014) · Brain Pathology · doi:10.1111/bpa.12099 · Cited by 414
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.
O'Riordan, J. I., Gallagher, H. L., Thompson, A. J., Howard, R. S., Kingsley, D. P., Thompson, E. J., McDonald, W. I., & Miller, D. H. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.4.382 · Cited by 397
Pittock, S. J., Lennon, V. A., McKeon, A., Mandrekar, J., Weinshenker, B. G., Lucchinetti, C. F., O'Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 395
Self-citationRamanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515593406 · Cited by 384
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Di Pauli, F., Rostásy, K., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 375
Mandler, R. N., Ahmed, W., & Dencoff, J. E. (1998) · Neurology · doi:10.1212/wnl.51.4.1219 · Cited by 366
Varrin‐Doyer, M., Spencer, C. M., Schulze‐Topphoff, U., Nelson, P. A., Stroud, R. M., C. Cree, B. A., & Zamvil, S. S. (2012) · Annals of Neurology · doi:10.1002/ana.23651 · Cited by 341
Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica
Misu, T., Fujihara, K., Nakashima, I., Sato, S., & Itoyama, Y. (2005) · Neurology · doi:10.1212/01.wnl.0000183151.19351.82 · Cited by 341
Epidemiology of aquaporin‐4 autoimmunity and neuromyelitis optica spectrum
Flanagan, E. P., Cabre, P., Weinshenker, B. G., Sauver, J. S., Jacobson, D. J., Majed, M., Lennon, V. A., Lucchinetti, C. F., McKeon, A., Matiello, M., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24617 · Cited by 338
Self-citationMolecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Hinson, S. R., Romero, M. F., Popescu, B. F. G., Lucchinetti, C. F., Fryer, J. P., Wolburg, H., Fallier-Becker, P., Noell, S., & Lennon, V. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109980108 · Cited by 328
A secondary progressive clinical course is uncommon in neuromyelitis optica
Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., Lennon, V. A., & Weinshenker, B. G. (2007) · Neurology · doi:10.1212/01.wnl.0000254502.87233.9a · Cited by 326
Self-citationA 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Kim, S.-H., Huh, S.-Y., Lee, S. J., Joung, A., & Kim, H. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3071 · Cited by 324
Palace, J., Leite, M. I., Nairne, A., & Vincent, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.188 · Cited by 322
CNS aquaporin-4 autoimmunity in children
McKeon, A., Lennon, V. A., Lotze, T., Tenenbaum, S., Ness, J. M., Rensel, M., Kuntz, N. L., Fryer, J. P., Homburger, H., Hunter, J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000314832.24682.c6 · Cited by 322
Self-citationTreatment of Neuromyelitis Optica With Mycophenolate Mofetil: Retrospective Analysis of 24 Patients
Jacob, A., Matiello, M., Weinshenker, B. G., Wingerchuk, D. M., Lucchinetti, C., Shuster, E., Carter, J., Keegan, B. M., Kantarci, O. H., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.175 · Cited by 308
Self-citationMealy, M. A., Wingerchuk, D. M., Palace, J., Greenberg, B. M., & Levy, M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5699 · Cited by 302
Self-citationNeuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications
Popescu, B. F. G., Lennon, V. A., Parisi, J. E., Howe, C. L., Weigand, S. D., Cabrera-Gómez, J. A., Newell, K., Mandler, R. N., Pittock, S. J., Weinshenker, B. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318214332c · Cited by 296
Self-citationFailure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Kleiter, I. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.216 · Cited by 294
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study
Araki, M., Matsuoka, T., Miyamoto, K., Kusunoki, S., Okamoto, T., Murata, M., Miyake, S., Aranami, T., & Yamamura, T. (2014) · Neurology · doi:10.1212/wnl.0000000000000317 · Cited by 284
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica
Watanabe, S., Nakashima, I., Misu, T., Miyazawa, I., Shiga, Y., Füjihara, K., & Itoyama, Y. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071174 · Cited by 284
Min, J.-H., Kim, B. J., & Lee, K. H. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511431973 · Cited by 280
The history of neuromyelitis optica
Jarius, S., & Wildemann, B. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-8 · Cited by 279
Zamvil, S. S., & Slavin, A. J. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000062 · Cited by 276
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Banwell, B., Tenembaum, S., Lennon, V. A., Ursell, E., Kennedy, J., Bar-Or, A., Weinshenker, B. G., Lucchinetti, C. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000284600.80782.d5 · Cited by 263
Self-citationTreatment of neuromyelitis optica: state-of-the-art and emerging therapies
Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.141 · Cited by 262
Treatment of neuromyelitis optica: review and recommendations
Kimbrough, D. J., Fujihara, K., Jacob, A., Lana-Peixoto, M. A., Isabel Leite, M., Levy, M., Marignier, R., Nakashima, I., Palace, J., de Seze, J., et al. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2012.06.002 · Cited by 260
Self-citationA population-based study of neuromyelitis optica in Caucasians
Asgari, N., Lillevang, S. T., Skejoe, H. P. B., Falah, M., Stenager, E., & Kyvik, K. O. (2011) · Neurology · doi:10.1212/wnl.0b013e3182190f74 · Cited by 257
Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica
Tradtrantip, L., Zhang, H., Saadoun, S., Phuan, P., Lam, C., Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2012) · Annals of Neurology · doi:10.1002/ana.22657 · Cited by 253
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Kleiter, I., Ruprecht, K., Asgari, N., Pitarokoili, K., Borisow, N., Hümmert, M. W., Trebst, C., Pache, F., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0719-z · Cited by 252
Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders
Flanagan, E. P., Weinshenker, B. G., Krecke, K. N., Lennon, V. A., Lucchinetti, C. F., McKeon, A., Wingerchuk, D. M., Shuster, E. A., Jiao, Y., Horta, E. S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2137 · Cited by 249
Self-citationNeuromyelitis optica: Passive transfer to rats by human immunoglobulin
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.085 · Cited by 249
Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
Costanzi, C., Matiello, M., Lucchinetti, C. F., Weinshenker, B. G., Pittock, S. J., Mandrekar, J., Thapa, P., & McKeon, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31822a2780 · Cited by 249
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Pache, F., Zimmermann, H., Mikolajczak, J., Schumacher, S., Lacheta, A., Oertel, F. C., Bellmann-Strobl, J., Jarius, S., Wildemann, B., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0720-6 · Cited by 246
Abboud, H., Petrak, A., Mealy, M., Sasidharan, S., Siddique, L., & Levy, M. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515581438 · Cited by 245
Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study
Takano, R., Misu, T., Takahashi, T., Sato, S., Fujihara, K., & Itoyama, Y. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e2414b · Cited by 239
Pittock, S. J., & Lucchinetti, C. F. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12794 · Cited by 227
Kim, S.-H., Jeong, I. H., Hyun, J.-W., Joung, A., Jo, H.-J., Hwang, S.-H., Yun, S., Joo, J., & Kim, H. J. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1276 · Cited by 211
Ayzenberg, I., Kleiter, I., Schröder, A., Hellwig, K., Chan, A., Yamamura, T., & Gold, R. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1246 · Cited by 206
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients
Leite, M. I., Coutinho, E., Lana-Peixoto, M., Apostolos, S., Waters, P., Sato, D., Melamud, L., Marta, M., Graham, A., Spillane, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825644ff · Cited by 203
An epidemiological study of neuromyelitis optica in Cuba
Cabrera-Gómez, J. A., Kurtzke, J. F., González-Quevedo, A., & Lara-Rodríguez, R. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0009-0 · Cited by 184
Saadoun, S., Waters, P., MacDonald, C., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2012) · Annals of Neurology · doi:10.1002/ana.22686 · Cited by 182
B lymphocytes in neuromyelitis optica
Bennett, J. L., O'Connor, K. C., Bar-Or, A., Zamvil, S. S., Hemmer, B., Tedder, T. F., von Büdingen, H.-C., Stuve, O., Yeaman, M. R., Smith, T. J., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000104 · Cited by 182
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
Watanabe, S., Misu, T., Miyazawa, I., Nakashima, I., Shiga, Y., Fujihara, K., & Itoyama, Y. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077189 · Cited by 172
Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens
Cree, B., Spencer, C. M., Varrin‐Doyer, M., Baranzini, S. E., & Zamvil, S. S. (2016) · Annals of Neurology · doi:10.1002/ana.24718 · Cited by 157
Khanna, S., Sharma, A., Huecker, J. B., Gordon, M. O., Naismith, R. T., & Stavern, G. P. V. (2012) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318254c62d · Cited by 154
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.
Zhang, H., & Verkman, A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67554 · Cited by 151
Clinical utility of testing AQP4-IgG in CSF
Majed, M., Fryer, J. P., McKeon, A. B., Lennon, V. A., & Pittock, S. J. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000231 · Cited by 149
Phuan, P.-W., Ratelade, J., Rossi, A., Tradtrantip, L., & Verkman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344325 · Cited by 146
Matiello, M., Kim, H. J., Kim, W., Brum, D. G., Barreira, A. A., Kingsbury, D. J., Plant, G. T., Adoni, T., & Weinshenker, B. G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ea9f15 · Cited by 144
Self-citationNeuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
Saadoun, S., Waters, P. J., Owens, G. P., Bennett, J. L., Vincent, A. C., & Papadopoulos, M. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-35 · Cited by 143
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Brum, D. G., Barreira, A. A., dos Santos, A. C., Kaimen-Maciel, D. R., Matiello, M., Costa, R. M., Deghaide, N. H. S., Costa, L. S., Louzada‐Júnior, P., Diniz, P. R. B., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509350741 · Cited by 139
Yoshimura, S., Isobe, N., Matsushita, T., Yonekawa, T., Masaki, K., Sato, S., Kawano, Y., & Kira, J. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302925 · Cited by 137
Pandit, L., & Kundapur, R. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514521503 · Cited by 135
Elsone, L., Kitley, J., Luppe, S., Lythgoe, D. T., Mutch, K., Jacob, S., Brown, R. L., Moss, K., McNeillis, B., Goh, Y. Y., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514525870 · Cited by 128
Wingerchuk, D. M., & Weinshenker, B. G. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0007-z · Cited by 122
Self-citationJeong, I. H., Park, B., Kim, S., Hyun, J., Joo, J., & Kim, H. J. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515587752 · Cited by 121
Characteristics of Devic's disease (neuromyelitis optica) in Mexico
Rivera, J. F., Kurtzke, J. F., Booth, V. J. A., & Corona, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0781-2 · Cited by 119
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
Kieseier, B. C., Stüve, O., Dehmel, T., Goebels, N., Leussink, V. I., Mausberg, A. K., Ringelstein, M., Turowski, B., Aktaş, O., Antoch, G., et al. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.668 · Cited by 118
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
Blanc, F., Noblet, V., Jung, B., Rousseau, F., Renard, F., Bourre, B., Longato, N., Cremel, N., Bitonto, L. D., Kleitz, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033878 · Cited by 117
Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
Huh, S., Kim, S., Hyun, J., Joung, A., Park, M. S., Kim, B., & Kim, H. J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2057 · Cited by 117
Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis
Etemadifar, M., Nasr, Z., Khalili, B., Taherioun, M., & Vosoughi, R. (2015) · Multiple Sclerosis International · doi:10.1155/2015/174720 · Cited by 113
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
Kleiter, I., & Gold, R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0400-8 · Cited by 105
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan
Houzen, H., Niino, M., Hirotani, M., Fukazawa, T., Kikuchi, S., Tanaka, K., & Sasaki, H. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.08.032 · Cited by 103
The prevalence of neuromyelitis optica in South East Wales
Cossburn, M., Tackley, G., Baker, K., Ingram, G., Burtonwood, M. T., Malik, G., Pickersgill, T. P., Naudé, J. T. W., & Robertson, N. P. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03529.x · Cited by 101
Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
Zéphir, H., Bernard‐Valnet, R., Lebrun‐Frénay, C., Outteryck, O., Audoin, B., Bourre, B., Pittion, S., Wiertlewski, S., Ouallet, J., Neau, J., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7852-y · Cited by 99
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
Kim, S., Kim, W., Park, M. S., Sohn, E. H., Li, X. F., & Kim, H. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.322 · Cited by 98
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom
Jacob, A., Panicker, J., Lythgoe, D. T., Elsone, L., Mutch, K., Wilson, M., Das, K., & Boggild, M. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6926-y · Cited by 97
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.157 · Cited by 94
Kitley, J., Elsone, L., George, J., Waters, P. J., Woodhall, M. R., Vincent, A. C., Jacob, A., Leite, M. I., & Palace, J. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304774 · Cited by 93
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures
Howe, C. L., Kaptzan, T., Magaña, S. M., Ayers-Ringler, J. R., LaFrance‐Corey, R. G., & Lucchinetti, C. F. (2014) · Glia · doi:10.1002/glia.22635 · Cited by 92
Tradtrantip, L., Zhang, H., Anderson, M. O., Saadoun, S., Phuan, P., Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2012) · The FASEB Journal · doi:10.1096/fj.11-201608 · Cited by 84
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica
Matiello, M., Schaefer-Klein, J. L., Sun, D. A., & Weinshenker, B. G. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3124 · Cited by 83
Self-citationIkeda, K., Kiyota, N., Kuroda, H., Sato, D. K., Nishiyama, S., Takahashi, T., Misu, T., Nakashima, I., Fujihara, K., & Aoki, M. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514551455 · Cited by 71
Neuromyelitis Optica Study Group (NEMOS), Ayzenberg, I., Schöllhammer, J., Hoepner, R., Hellwig, K., Ringelstein, M., Aktaş, O., Kümpfel, T., Krumbholz, M., Trebst, C., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-015-7991-1 · Cited by 64
Figueroa, M., Guo, Y. X., Tselis, A. C., Pittock, S. J., Lennon, V. A., Lucchinetti, C. F., & Lisak, R. P. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6331 · Cited by 63
Role of membrane complement regulators in neuromyelitis optica
Saadoun, S., & Papadopoulos, M. C. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515571446 · Cited by 63
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO
Gelfand, J. M., Cotter, J. A., Klingman, J. G., Huang, E. J., & Cree, B. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000034 · Cited by 60
Intractable Nausea and Vomiting From Autoantibodies Against a Brain Water Channel
Iorio, R., Lucchinetti, C. F., Lennon, V. A., Farrugia, G., Pasricha, P. J., Weinshenker, B. G., & Pittock, S. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.021 · Cited by 55
Self-citationGenetic analysis of aquaporin-4 in neuromyelitis optica
Matiello, M., Schaefer-Klein, J. L., Hebrink, D. D., Kingsbury, D. J., Atkinson, E. J., & Weinshenker, B. G. (2011) · Neurology · doi:10.1212/wnl.0b013e31822f045b · Cited by 54
Self-citationIs neuromyelitis optica with advanced age of onset a paraneoplastic disorder?
Ontaneda, D., & Fox, R. J. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.854208 · Cited by 49
An epidemiological study of neuromyelitis optica in Isfahan
Etemadifar, M., Dashti, M., Vosoughi, R., Abtahi, S.-H., Ramagopalan, S. V., & Nasr, Z. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514537699 · Cited by 47
Jarius, S., & Wildemann, B. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6355-8 · Cited by 42
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG
Caulfield, M. E., Guo, Y. X., Johnson, R. K., McCarthy, C. B., Fitz‐Gibbon, P. D., Lucchinetti, C. F., & Howe, C. L. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0403-8 · Cited by 41
An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS
Jarius, S., & Wildemann, B. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511411758 · Cited by 33
European Ancestry Predominates in Neuromyelitis Optica and Multiple Sclerosis Patients from Brazil
Brum, D. G., Luizon, M. R., dos Santos, A. C., Lana–Peixoto, M. A., Rocha, C. F., Brito, M. L., de Oliveira, E. M. L., Bichuetti, D. B., Gabbai, A. A., Diniz, D. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058925 · Cited by 26
Neuromyelitis optica in a child with Aicardi-GoutiÈres syndrome
Hacohen, Y., Zuberi, S. M., Vincent, A. C., Crow, Y. J., & Cordeiro, N. (2015) · Neurology · doi:10.1212/wnl.0000000000001792 · Cited by 24
Arellano, B., Hussain, R. Z., Zacharias, T., Yoon, J. C., David, C. S., Zein, S., Steinman, L., Forsthuber, T. G., Greenberg, B. M., Lambracht‐Washington, D., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1300 · Cited by 17
Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica
Moussawi, K., Lin, D. J., Matiello, M., Chew, S., Morganstern, D., & Vaitkevicius, H. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.08.006 · Cited by 13
No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica
Liu, Q.-B., Li, Z., Zhao, G., Yu, H., & Wu, Z. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1457-1 · Cited by 9
Cited by
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Pittock, S. J., Berthele, A., Fujihara, K., Kim, H. J., Levy, M., Palace, J., Nakashima, I., Terzi, M., Totolyan, N., Viswanathan, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900866 · Cited by 872
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Yamamura, T., Kleiter, I., Fujihara, K., Palace, J., Greenberg, B., Zakrzewska-Pniewska, B., Patti, F., Tsai, C.-P., Saiz, A., Yamazaki, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901747 · Cited by 664
Traboulsee, A., Greenberg, B. M., Bennett, J. L., Szczechowski, L., Fox, E., Shkrobot, S., Yamamura, T., Terada, Y., Kawata, Y., Wright, P., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30078-8 · Cited by 513
Self-citationLópez-Chiriboga, A. S., Majed, M., Fryer, J., Dubey, D., McKeon, A., Flanagan, E. P., Jitprapaikulsan, J., Kothapalli, N., Tillema, J.-M., Chen, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1814 · Cited by 410
Self-citation
Metadata
- Authors
- Weinshenker, B. G., & Wingerchuk, D. M.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 92
- Issue
- 4
- Pages
- 663-679
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2604845570
- Cited by
- 286
- References
- 113
- FWCI
- 19.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.